Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study (Q35136181)

6 August 2017

Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study (English)

1 reference

6 August 2017

Gram-negative bacteria

0 references

2

Paul M

1 reference

6 August 2017

Leibovici L

1

1 reference

6 August 2017

Poznanski O

3

1 reference

6 August 2017

Drucker M

4

1 reference

6 August 2017

Samra Z

5

1 reference

6 August 2017

Konigsberger H

6

1 reference

6 August 2017

Pitlik SD

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

1 reference

6 August 2017

41

1 reference

6 August 2017

5

1 reference

6 August 2017

1127-1133

1 reference

Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163862

In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163862

Analysis of 1,186 Episodes of Gram-Negative Bacteremia in Non-University Hospitals: The Effects of Antimicrobial Therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163862

A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163862

Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163862

Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163862

Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163862

Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163862

Long-term survival and function after suspected gram-negative sepsis.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163862

Pseudomonas bacteremia. Retrospective analysis of 410 episodes

27 September 2018

1 reference

12 December 2020

Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989

1 reference

12 December 2020

Long-term survival following bacteremia or fungemia

1 reference

12 December 2020

The dissociation between aminoglycoside serum concentrations and nephrotoxicity

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.41.5.1127

0 references

PMCID

163862

1 reference

6 August 2017

1 reference